IP Library › Granted Patent US 8,257,244
Granted Patent B2
US 8,257,244 · App. 10/485,611 · Granted Sep 4, 2012

Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity

Assignee: Anecova SA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,257,244
App. No.
10/485,611
Granted
Sep 4, 2012
Kind
B2
Abstract

A retrievable intrauterine device for placing within a uterine cavity one or more encapsulated elements capable of having interactions with uterine fluid comprising an intrauterine device loaded with the encapsulated elements.

Claims (25)

1. A method of performing in utero preimplantatory incubation of an embryo or a zygote in assisted reproductive technology, comprising the steps of:

providing one or more element(s) comprising an embryo, a zygote, male and/or female gametes, a fertilized oocyte, or any combination thereof,

providing a retrievable intrauterine device comprising a capsule capable of being loaded with one or more elements comprising an embryo, a zygote, male and/or female gametes, a fertilized oocyte, or any combination thereof,

wherein said capsule comprises a material that permits passage of proteins from a uterine cavity to said elements loaded in said capsule, when said device is placed in the uterine cavity,

loading said capsule in said device with said element(s),

placing said device within the uterine cavity of a mammal,

retrieving and removing the device from the uterine cavity along with the encapsulated element(s) after incubation of said element(s) in contact with uterine fluids in said capsule,

further retrieving an embryo or a zygote from said capsule.

2. The method of claim 1 , wherein said element(s) comprise male and/or female gametes.

3. The method of claim 1 , wherein said device is adapted for stable placement of the device in the uterus.

4. The method of claim 1 , wherein said capsule comprises a polymeric material.

5. The method of claim 4 , wherein said polymeric material comprises polyethersulfone, polyacrylates and acrylate copolymers, polyvinylidienes, polyurethanes, or a mixture thereof.

6. The method of claim 1 , wherein said material that permits passage of proteins comprises a selectively permeable membrane with an adapted pore size.

7. The method of claim 6 , wherein said membrane comprises a polyethersulfone.

8. The method of claim 1 , wherein said material that permits passage of proteins has a molecular weight cutoff ranging from 50,000 to 1 million Daltons.

9. The method of claim 8 , wherein the molecular weight cutoff is equal to or greater than 150,000 Daltons.

10. The method of claim 1 , wherein material that permits passage of proteins has a molecular weight cutoff equal to or greater than 1 million Daltons.

11. The method of claim 1 , wherein the device is loaded with an embryo or a zygote.

12. The method of claim 1 , wherein said mammal is a human.

13. The method of claim 1 , further comprising the step of:

implanting the retrieved embryo or zygote into the uterine cavity of said mammal.

14. The method of claim 1 , further comprising the step of:

freezing the retrieved embryo or zygote for cryopreservation.

15. The method of claim 1 , further comprising the step of:

in-vitro culture of the embryo or zygote prior to implantation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2004
From: MOCK, PASCAL
To: ANECOVA SA
Reel/Frame 015800/0931 →
Continuity (2)
Provisional Application 60309274 · Aug 1, 2001
Related Publication 20040261799A1 · Dec 30, 2004